Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · IEX Real-Time Price · USD
4.540
-0.070 (-1.52%)
At close: Jul 2, 2024, 4:00 PM
4.520
-0.020 (-0.44%)
After-hours: Jul 2, 2024, 6:49 PM EDT
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $373.36 million as of July 2, 2024. Its market cap has decreased by -32.95% in one year.
Market Cap
373.36M
Enterprise Value
111.33M
1-Year Change
-32.95%
Ranking
Category
Stock Price
$4.54
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $373.36M, a decrease of -42.53%. That is a compound annual growth rate of -6.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 379.10M | -54.18% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
| Feb 3, 2016 | 649.70M | - |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 384.96M |
| AC Immune | 383.90M |
| Fulcrum Therapeutics | 379.14M |
| IGM Biosciences | 377.75M |
| Precigen | 376.11M |
| Nkarta | 370.66M |
| Talkspace | 369.91M |
| Bioventus | 368.92M |